P&G Drops $3.8 Billion on Thorne Supplement Brand

Procter & Gamble (PG) has made a significant move into the wellness market by agreeing to acquire premium supplement brand Thorne for $3.8 billion.

The deal, announced on Tuesday, marks a major investment in the health-focused consumer segment and is expected to revitalize P&G's sluggish healthcare division.

Thorne, which was founded in 1984 and went public in late 2021 with a valuation of $525 million, has seen its value multiply more than five-fold in less than three years. The company surpassed $500 million in annual revenue in 2025 and is projected to hit $650 million in sales in 2026.

P&G CEO Shailesh Jejurikar expressed confidence in the deal, stating that Thorne is a 'really well-run operation' with a strong direct-to-consumer sales channel. The acquisition is seen as a strategic move by P&G to capture younger, health-focused consumers and tap into the growing supplement market.